SciELO - Scientific Electronic Library Online

 
vol.52 issue5Electrocardiogram analysis by the anesthesiologistComplex regional pain syndrome: epidemiology, pathophysiology, clinical manifestations, diagnostic tests and therapeutic proposals author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Revista Brasileira de Anestesiologia

Print version ISSN 0034-7094On-line version ISSN 1806-907X

Abstract

BAGATINI, Airton; GOMES, Cláudio Roberto; MASELLA, Marcelo Zanettini  and  REZER, Gabrielle. Dexmedetomidine: pharmacology and clinical application. Rev. Bras. Anestesiol. [online]. 2002, vol.52, n.5, pp.606-617. ISSN 0034-7094.  http://dx.doi.org/10.1590/S0034-70942002000500012.

BACKGROUND AND OBJECTIVES: Dexmedetomidine is the newest a2-adrenergic agonist for clinical application. It has a fast onset, is metabolized by the liver and mostly excreted by the urine. This review aimed at presenting pharmacokinetic and pharmacodynamic profiles of dexmedetomidine and its clinical applications. CONTENTS: Dexmedetomidine pharmacokinetic and pharmacodynamic profiles are presented and compared to other a2-adrenergic agonist drugs, the prototype of which is clonidine. Cardiac, vascular, neurological and gynecologic procedure outcomes are commented. CONCLUSIONS: Dexmedetomidine is an innovative drug for sedation and analgesia. Its major qualities are fast onset and titration, allowing for changes in sedation and analgesia depth. In addition, it has a synergism with commonly used anesthetic drugs, with a low incidence of side effects and minor respiratory depression.

Keywords : DRUGS [clonidine]; DRUGS [dexmedetomidine].

        · abstract in Portuguese | Spanish     · text in Portuguese     · Portuguese ( pdf epdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License